{"id":710,"date":"2012-02-10T12:52:38","date_gmt":"2012-02-10T12:52:38","guid":{"rendered":"https:\/\/blogs.bmj.com\/jfprhc\/?p=710"},"modified":"2012-02-11T10:52:25","modified_gmt":"2012-02-11T10:52:25","slug":"faculty-news","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmjsrh\/2012\/02\/10\/faculty-news\/","title":{"rendered":"Faculty News"},"content":{"rendered":"

Amendments to FSRH Guidance Documents: Drug Interactions and Emergency Contraception<\/span>
\n<\/strong>Drug Interactions (2011)<\/a>: Page 9 of the original version of this CEU Guidance Document (issued in January 2011) incorrectly stated that the interaction between lamotrigine and combined hormonal contraception (CHC) only applies to lamotrigine monotherapy. CHC also reduces lamotrigine levels when lamotrigine is combined with antiepileptic drugs that
\ndo not alter its metabolism.<\/p>\n

Emergency Contraception (2011)<\/a>: The original version of this CEU Guidance Document (issued in August 2011) contained some inconsistencies that the CEU has corrected in this version. These amendments are as follows: additional recommendation regarding offering a Cu-IUD to eligible women presenting between 0 and 120 hours of UPSI or within 5 days of expected ovulation added (pages ii and 8); references 12 and 13 updated (page 11); and acknowledgement of chart designer added to Appendix 2 (page 15).<\/p>\n

New Examiners for the Multiple Choice Question Paper (MCQ)<\/span>
\n<\/strong>The Examination Committee invites applications to join the MCQ Examiner Group of the MFSRH Panel of Examiners. Applicants should be accredited Members of the Faculty and active clinically in the sphere of the Faculty or, to be Clinicians, of equivalent status, with an interest in Sexual and Reproductive Healthcare but whose speciality is GUM, Public Health Medicine, Gynaecology or Primary Care. Further information and application forms from the Faculty website<\/a>, closing date 29th February.<\/p>\n

Committee Vacancies<\/strong><\/span><\/p>\n